Mixed incontinence: Current evidence and future perspectives

Neurourology and Urodynamics

Volumn 29, Issue 4, 2010, Pages 618-622

  Khullar, Vik ^a   Cardozo, Linda ^b   Dmochowski, Roger ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Lower urinary tract symptoms; Mixed incontinence; OAB; Research

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; DULOXETINE OXALATE; ESTROGEN; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOLTERODINE;

BEHAVIOR THERAPY; BLADDER CAPACITY; CLINICAL TRIAL; COLPOSUSPENSION; CONSERVATIVE TREATMENT; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROSTIMULATION; ESTROGEN THERAPY; FATIGUE; HUMAN; MIXED INCONTINENCE; NAUSEA; NONHUMAN; PELVIC FLOOR MUSCLE TRAINING; POSTMENOPAUSE; REVIEW; STRESS INCONTINENCE; TENSION FREE VAGINAL TAPE; TREATMENT RESPONSE; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URODYNAMICS;

ADRENERGIC UPTAKE INHIBITORS; BENZHYDRYL COMPOUNDS; CLINICAL TRIALS AS TOPIC; CRESOLS; ESTROGENS; FEMALE; HUMANS; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; TIME FACTORS; TREATMENT OUTCOME; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS; URINARY INCONTINENCE, URGE;

EID: 77953605064     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20907     Document Type: Review

References (47)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-178 (Pubitemid 34195211)
2. Lagro-Janssen ALM, Debruyne FMJ, van Weel C. Value of the patient's case history in diagnosing urinary incontinence in general practice. Br J Urol 1991;67:569-572
3. Seigel SW, Richardson DA, Miller KL, et al. Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women. Urology 1997;50:934-940
4. Karram MM, Bhatia NN. Management of coexistent stress and urge urinary incontinence. Obstet Gynecol 1989;73:4-7.
5. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-336
6. Diokno AC, Brock BM, Brown MB, et al. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 1986;136:1022-1025
7. Lemack GE, Zimmern PE. Predictability of urodynamic findings based on the urogenital distress inventory-6 questionnaire. Urology 1999;54:461-466
8. Wells TJ, Brink CA, Diokno AC. Urinary incontinence in elderly women: Clinical findings. J Am Geriatr Soc 1987;35:933-939
9. Bump RC, Norton PA, Zinner NR, et al. Mixed urinary incontinence symptoms: Urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol 2003;102:76-83.
10. Hannestad YS, Rortveit G, Sandvik H, et al. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPICONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000;53:1150-1157
11. Bump RC. Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstet Gynecol 1993;81:421-425
12. Webb RJ, Ramsden PD, Neal DE. Ambulatory monitoring and electronic measurement of urinary leakage in the diagnosis of detrusor instability and incontinence. Br J Urol 1991;68:148-152
13. Summitt RL, Jr., Stovall TG, Bent AE, et al. Urinary incontinence: Correlation of history and brief office evaluation with multichannel urodynamic testing. Am J Obstet Gynecol 1992;166:1835-1844
14. Radley SC, Rosario DJ, Chapple CR, et al. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol 2001;166:2253-2258
15. Robertson AS, Griffiths CJ, Ramsden PD, et al. Bladder function in healthy volunteers: Ambulatory monitoring and conventional urodynamic studies. Br J Urol 1994;3:242-249
16. van Waalwijk van Doorn ES, Remmers A, Janknegt RA. Conventional and extramural ambulatory urodynamic testing of the lower urinary tract in female volunteers. J Urol 1992;5:1319-1325, discussion 1326.
17. Salvatore S, Khullar V, Anders K, et al. Reducing artifacts in ambulatory urodynamics. Br J Urol 1998;81:211-214
18. Versi E, Cardozo L, Anand D, et al. Symptoms analysis for the diagnosis of genuine stress incontinence. Br J Obstet Gynaecol 1991;98:815-819
19. Artibani W. Difficult to manage patient populations: Mixed symptomatology. BJU Int 2000;85:53-54
20. Khullar V, Digesu A, Chaliha C, et al. Mixed incontinence: How should it be treated? Neurourol Urodyn 2002;21:378-379 Abstract 73.
21. Scotti RJ, Angell G, Flora R, et al. Antecedent history as a predictor of surgical cure of urgency symptoms in mixed incontinence. Obstet Gynecol 1998;91:51-54
22. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-260
23. Fantl JA, Cardozo LD, McClish DK, et al. Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994;83:12-18
24. Sultana CJ, Walters MD. Estrogen and urinary incontinence in women. Maturitas 1990;20:129-138
25. Hextall A. Oestrogens and lower urinary tract function. Maturitas 2000; 36:83-92.
26. de Groat WC, Yoshimura N. Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol 2001;41:691-721.
27. Norton PA, Zinner NR, Yalcin I, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40-48
28. Albanese A, Jenner P, Marsden CD, et al. Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci Lett 1988;87:46-50.
29. Kontani H, Inoue T, Sakai T. Dopamine receptor subtypes that induce hyperactive bladder response in anesthetized rats. Jpn J Pharmacol 1990;54: 482-486
30. Seki S, Igawa Y, Kaidoh K, et al. Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol Urodyn 2001;20:105-113
31. Yoshimura N, Sasa M, Yoshida O, et al. Dopamine D-1 receptor-mediated inhibition of micturition reflex by central dopamine from the substantia nigra. Neurourol Urodyn 1992;11:535-545
32. Yoshimura N, Mizuta E, Kuno S, et al. The dopamineD1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuropharmacology 1993;32:315-321
33. Yoshimura N, Mizuta E, Yoshida O, et al. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridinelesioned parkinsonian cynomolgus monkeys. J Pharmacol Exp Ther 1998;286:228-233
34. Yokoyama O, Yoshiyama M, Namiki M, et al. Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am J Physiol 1999;276:R935-42.
35. Chen SY, Wang SD, Cheng CL, et al. Glutamate activation of neurons in CVreactive areas of the cat brain stem affects urinary bladder motility. Am J Physiol 1993;265:F520-9.
36. Danuser H, Thor KB. Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. Br J Pharmacol 1996; 118:150-154
37. Espey MJ, Du H-J, Downie JW. Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats. Brain Res 1998;798:101-108
38. McMahon SB, Spillane K. Brain stem influences on the parasympathetic supply to the urinary bladder of the cat. Brain Res 1982;234:237-249
39. Sorbera LA, Castanẽr RM, Castanẽr J. Duloxetine oxalate. Drugs Future 2000;25:907-916
40. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995;274:1014-1024
41. Zinner N, Dmochowski R, Miklos J, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence (SUI). Neurourol Urodyn 2002;21: 343-344 Abstract 77.
42. Sand PK. Pelvic floor stimulation in the treatment of mixed incontinence complicated by a low-pressure urethra. Obstet Gynecol 1996;5:757-760
43. Stanton SL, Cardozo L, Williams JE, et al. Clinical and urodynamic features of failed incontinence surgery in the female. Obstet Gynecol 1978;51:515-520
44. Langer R, Ron-El R, Bukovsky I, et al. Colposuspension in patients with combined stress incontinence and detrusor instability. Eur Urol 1988;14: 437-439
45. Colombo M, Zanetta G, Vitobello D, et al. The Burch colposuspension for women with and without detrusor overactivity. Br J Obstet Gynaecol 1996;103:255-260 (Pubitemid 26072735)
46. Rezapour M, Ulmsten U. Tension-free vaginal tape (TVT) in women with mixed urinary incontinence: A longterm follow-up. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:S15-8. (Pubitemid 32605819)
47. Jeffry L, Deval B, Birsan A, et al. Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence. Urology 2001;58:702-706